Jefferies Financial Group Files 424B5 Prospectus

TL;DR

Jefferies Financial Group filed a prospectus update on 4/6/2026. Keep an eye on potential offerings.

AI Summary

Jefferies Financial Group Inc. filed a 424B5 prospectus on April 6, 2026, related to its Act 33 filing with file number 333-271881. The filing details are associated with CIK 0000096223 and EIN 132615557, with its principal office located at 520 Madison Avenue, New York, NY 10022.

Why It Matters

This filing indicates a potential offering or update to existing securities, which could impact investors and market perception of Jefferies Financial Group.

Risk Assessment

Risk Level: low — A 424B5 filing is a standard prospectus supplement and does not inherently indicate increased risk for the company.

Key Numbers

• 0000096223 — CIK (Jefferies Financial Group Inc. identifier)
• 132615557 — EIN (Employer Identification Number)
• 333-271881 — File Number (SEC registration file number)

Key Players & Entities

• Jefferies Financial Group Inc. (company) — Filer
• 0000096223 (company) — CIK
• 132615557 (company) — EIN
• 520 MADISON AVENUE NEW YORK NY 10022 (company) — Mailing Address
• 2124601900 (company) — Business Phone Number
• 333-271881 (dollar_amount) — File Number
• 2026-04-06 (date) — Filing Date

FAQ

Key Financial Figures

• $2,155,000 — 23 and Prospectus dated May 12, 2023) $2,155,000 Jefferies Jefferies Financial Group I
• $1,000 — e not required to do so. Issue Price: $1,000 per Note Stated Principal Amount: $1,
• $18.33 — will pay a Contingent Coupon Payment of $18.33 on the applicable Coupon Payment Date i
• $392.32 — to its Coupon Barrier. Initial Value: $392.32 with respect to the SMH; 24,045.53 with
• $294.24 — n the Valuation Date. Coupon Barrier: $294.24 with respect to the SMH (75% of its Ini
• $235.39 — f its Initial Value) Threshold Value: $235.39 with respect to the SMH (60% of its Ini
• $981.80 — Estimated value on the Pricing Date: $981.80 per Note. Please see "The Notes" below.
• $12,930 — iting Discounts and Commissions 0.60% $12,930 Proceeds to Jefferies Financial Group
• $2,142,070 — l Group Inc. (Before Expenses) 99.40% $2,142,070 Neither the Securities and Exchange Co
• $1.01 billion — 26: Investment Banking Net Revenues of $1.01 billion Capital Markets Net Revenues of $779 m
• $779 million — illion Capital Markets Net Revenues of $779 million Asset Management Net Revenues of $220
• $220 million — llion Asset Management Net Revenues of $220 million Pre-Tax Earnings from Continuing Opera
• $212 million — Earnings from Continuing Operations of $212 million Net Earnings Attributable to Common Sh
• $156 million — Attributable to Common Shareholders of $156 million (reflects a 24.9% effective tax rate)
• $0.00 — y per Note Return on the Notes 0.00 $0.00 -100.00% 50.00 $500.00 -50.00% 59.

Filing Documents

• ef20069950_424b5.htm (424B5) — 421KB
• exfilingfees.htm (EX-FILING FEES) — 25KB
• image01.jpg (GRAPHIC) — 20KB
• image02.jpg (GRAPHIC) — 6KB
• image10.jpg (GRAPHIC) — 4KB
• image00015.jpg (GRAPHIC) — 17KB
• image00016.jpg (GRAPHIC) — 18KB
• image00017.jpg (GRAPHIC) — 6KB
• image00018.jpg (GRAPHIC) — 9KB
• image00019.jpg (GRAPHIC) — 4KB
• image00020.jpg (GRAPHIC) — 4KB
• image00021.jpg (GRAPHIC) — 6KB
• image00022.jpg (GRAPHIC) — 3KB
• image00023.jpg (GRAPHIC) — 5KB
• image00024.jpg (GRAPHIC) — 4KB
• image00025.jpg (GRAPHIC) — 19KB
• 0001140361-26-013370.txt ( ) — 743KB
• exfilingfees_htm.xml (XML) — 4KB

RISK FACTORS

RISK FACTORS PS-8 THE UNDERLYINGS PS-14 HEDGING PS-27 SUPPLEMENTAL DISCUSSION OF U.S. FEDERAL INCOME TAX CONSEQUENCES PS-28 SUPPLEMENTAL PLAN OF DISTRIBUTION PS-33 CONFLICT OF INTEREST PS-38 LEGAL MATTERS PS-39 EXPERTS PS-40 You should rely only on the information contained in or incorporated by reference in this pricing supplement and the accompanying product supplement, prospectus and prospectus supplement. We have not authorized anyone to provide you with different information. We are not making an offer of these securities in any state where the offer is not permitted. You should not assume that the information contained in this pricing supplement or the accompanying product supplement, prospectus or prospectus supplement is accurate as of any date later than the date on the front of this pricing supplement. PS-i Table of Contents SPECIAL NOTE ON FORWARD-LOOKING STATEMENTS This pricing supplement and the accompanying product supplement, prospectus and prospectus supplement contain or incorporate by reference "forward-looking statements" within the meaning of the safe harbor provisions of Section 27A of the Securities Act of 1933 (the "Securities Act") and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are not statements of historical fact and represent only our belief as of the date such statements are made. There are a variety of factors, many of which are beyond our control, which affect our operations, performance, business strategy and results and could cause actual reported results and performance to differ materially from the performance and expectations expressed in these forward-looking statements. These factors include, but are not limited to, financial market volatility, actions and initiatives by current and future competitors, general economic conditions, controls and procedures relating to the close of the quarter, the effects of current, pending and future legislation or rulemakin

RISK FACTORS

RISK FACTORS In addition to the other information contained and incorporated by reference in this pricing supplement and the accompanying product supplement, prospectus and prospectus supplement, including the section entitled "Risk Factors" in our Annual Report on Form 10K, you should consider carefully the following factors before deciding to purchase the Notes. Structure-related Risks You may lose a significant portion or all of your investment. If the Final Value of the Worst-Performing Underlying is less than its Threshold Value, you will receive for each Note that you hold a Payment at Maturity that is less than the Stated Principal Amount of each Note. In this case investors will lose 1% of the Stated Principal Amount for every 1% decline in the Final Value below the Initial Value. Investors may lose up to 100% of the Stated Principal Amount of the Notes. Your investment return is limited to the return represented by the Contingent Coupon Payments, if any. Your investment return will be limited to the return represented by the Contingent Coupon Payments, if any, paid over the term of the Notes. You will not receive a payment on the Notes greater than the Stated Principal Amount plus any Contingent Coupon Payments, regardless of the appreciation of the Underlyings. In contrast, a direct investment in the Underlyings (or any securities, commodities or other assets represented by the Underlyings) would allow you to receive the full benefit of any appreciat